Delaware Court of Chancery Finds a Material Adverse Effect and Permits Termination of Merger Agreement

Published date05 October 2018
Law FirmWilson Sonsini Goodrich & Rosati
AuthorWilliam Chandler,David Berger,Amy Simmerman,Michael Ringler,Todd Cleary,Katherine Henderson,Ryan Greecher,Brad Sorrels,Robert Ishii,Randy Holland,Nate Emeritz
Subject MatterAcquisitions,Mergers,Whistleblowers,FDA,Merger Agreements,Material Adverse Effects,Contract Terms,Contract Termination,Pharmaceutical Industry

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT